Japanese University Finds New Drug Delivery Technology to Treat Glaucoma
This article was originally published in PharmAsia News
Executive Summary
Japan's Gifu Medical University research team discovered a granula with a diameter of 100 nanometers that can deliver drugs to the bottom of an eye to treat diabetic retinopathy and glaucoma without injection or an oral drug. The team led by Hirofumi Takeuchi and Hideaki Hara found the non-toxic granula will dissolve inside the body in mice studies. The team hopes to conduct further research to load the granula with active drug compounds. (Click here for more - Japanese language)
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.